Overall rank by patents
#25,828
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Axis holds 10 US patents across 2 technology areas, rank #25,828 of 50,000 tracked assignees.
Axis Spine Technologies Ltd. has been granted 10 US utility patents between 2023 and 2025, placing Axis Spine Technologies Ltd. at rank #25,828 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.5 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Axis Spine Technologies Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Axis sits between Averatek Corporation (10 patents, rank #25,824) and Aylus Networks, Inc. (10 patents, rank #25,832) - the closest US assignees by grant volume. The composite Innovation Score of 45.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Axis Spine Technologies Ltd.'s 20.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Axis Spine Technologies Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Averatek Corporation
10 patents
Avere Systems, Inc.
10 patents
Avocado Systems, Inc.
10 patents
Axine Water Technologies Inc.
10 patents
Axon Neuroscience SE
10 patents
Axus Technology, LLC
10 patents
Ayasdi, Inc.
10 patents
Aylus Networks, Inc.
10 patents
Axis Spine Technologies Ltd.
10 patents
What this shows Axis holds 10 patents at rank #25,828, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Axis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 10.0% |
| 2024 | 8 | 80.0% |
| 2025 | 1 | 10.0% |
Top 2 of 2 technology areas
Overall rank by patents
#25,828
Across all tracked assignees
45.6 out of 100
How to use this portfolio
Axis's 10 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.